Literature DB >> 18963906

Exploring stakeholder perceptions of acceptability and feasibility of needle exchange programmes, syringe vending machines and safer injection facilities in Tijuana, Mexico.

Morgan M Philbin1, Andrea Mantsios, Remedios Lozada, Patricia Case, Robin A Pollini, Jorge Alvelais, Carl A Latkin, Carlos Magis-Rodriguez, Steffanie A Strathdee.   

Abstract

BACKGROUND: Injection drug use is a growing public health crisis along the U.S.-Mexican border and rising rates of blood-borne infections highlight the pressing need for harm reduction interventions. We explored the acceptability and feasibility of such interventions in Tijuana, a city adjacent to San Diego, California.
METHODS: Using in-depth qualitative interviews conducted from August 2006-March 2007 with 40 key stakeholders - pharmacists, legal professionals, health officials, religious officials, drug treatment providers, and law enforcement personnel - we explored the acceptability and feasibility of interventions to reduce drug-related harm in Tijuana, Mexico. Interviews were taped with consent, transcribed verbatim, and translated. Content analysis was conducted to identify themes which included barriers, structural limitations, and suggestions for implementation.
RESULTS: Topics included acceptance and feasibility of needle exchange programmes (NEPs), syringe vending machines, and safer injection facilities (SIFs), structural barriers and suggestions for implementation. Of these interventions, NEPs were deemed the most acceptable (75%); however, only half believed these could be feasibly implemented, citing barriers involving religion, police, and lack of political will, public awareness, and funding.
CONCLUSIONS: Increasing HIV infection rates among injection drug users in Tijuana have prompted interest in public health responses. Our results may assist policy strategists in implementing social-structural interventions that will help create enabling environments that facilitate the scale-up and implementation of harm reduction in Tijuana.

Entities:  

Mesh:

Year:  2008        PMID: 18963906      PMCID: PMC2727467          DOI: 10.1016/j.drugpo.2008.09.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  34 in total

Review 1.  Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy.

Authors:  D Vlahov; D C Des Jarlais; E Goosby; P C Hollinger; P G Lurie; M D Shriver; S A Strathdee
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

2.  The social structural production of HIV risk among injecting drug users.

Authors:  Tim Rhodes; Merrill Singer; Philippe Bourgois; Samuel R Friedman; Steffanie A Strathdee
Journal:  Soc Sci Med       Date:  2005-03-19       Impact factor: 4.634

3.  "Vivo para consumirla y la consumo para vivir" ["I live to inject and inject to live"]: high-risk injection behaviors in Tijuana, Mexico.

Authors:  Steffanie A Strathdee; Wendy Davila Fraga; Patricia Case; Michelle Firestone; Kimberly C Brouwer; Saida Gracia Perez; Carlos Magis; Miguel Angel Fraga
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

4.  Controlling HIV among injecting drug users: the current status of harm reduction.

Authors:  Alex Wodak
Journal:  HIV AIDS Policy Law Rev       Date:  2006-12

5.  Rates of HIV/AIDS care and antiretroviral therapy response among active injection drug users.

Authors:  Evan Wood; Thomas Kerr; Mark W Tyndall; Ruth Zhang; Robert S Hogg; Steffanie A Strathdee; Julio S G Montaner
Journal:  Addiction       Date:  2007-09       Impact factor: 6.526

Review 6.  Rapid scale up of harm reduction in China.

Authors:  Sheena G Sullivan; Zunyou Wu
Journal:  Int J Drug Policy       Date:  2007-02-14

7.  Malaysia and harm reduction: the challenges and responses.

Authors:  Gary Reid; Adeeba Kamarulzaman; Sangeeta Kaur Sran
Journal:  Int J Drug Policy       Date:  2007-01-29

Review 8.  The role of qualitative research in HIV/AIDS.

Authors:  R Power
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

9.  Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico.

Authors:  Kimberly C Brouwer; Steffanie A Strathdee; Carlos Magis-Rodríguez; Enrique Bravo-García; Cecilia Gayet; Thomas L Patterson; Stefano M Bertozzi; Robert S Hogg
Journal:  J Urban Health       Date:  2006-03       Impact factor: 3.671

10.  Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico.

Authors:  Steffanie A Strathdee; Remedios Lozada; Robin A Pollini; Kimberly C Brouwer; Andrea Mantsios; Daniela A Abramovitz; Tim Rhodes; Carl A Latkin; Oralia Loza; Jorge Alvelais; Carlos Magis-Rodriguez; Thomas L Patterson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-03-01       Impact factor: 3.731

View more
  14 in total

1.  Drug-related behaviors independently associated with syphilis infection among female sex workers in two Mexico-US border cities.

Authors:  Oralia Loza; Thomas L Patterson; Melanie Rusch; Gustavo A Martínez; Remedios Lozada; Hugo Staines-Orozco; Carlos Magis-Rodríguez; Steffanie A Strathdee
Journal:  Addiction       Date:  2010-04-27       Impact factor: 6.526

2.  The emerging HIV epidemic on the Mexico-U.S. border: an international case study characterizing the role of epidemiology in surveillance and response.

Authors:  Steffanie A Strathdee; Carlos Magis-Rodriguez; Vickie M Mays; Richard Jimenez; Thomas L Patterson
Journal:  Ann Epidemiol       Date:  2012-06       Impact factor: 3.797

3.  Deportation experiences of women who inject drugs in Tijuana, Mexico.

Authors:  Angela M Robertson; Remedios Lozada; Alicia Vera; Lawrence A Palinkas; José Luis Burgos; Carlos Magis-Rodriguez; Gudelia Rangel; Victoria D Ojeda
Journal:  Qual Health Res       Date:  2011-09-13

4.  Correlates of seeking injection assistance among injection drug users in Tijuana, Mexico.

Authors:  Angela M Robertson; Alicia Y Vera; Manuel Gallardo; Robin A Pollini; Thomas L Patterson; Patricia Case; Lucie Nguyen; Steffanie A Strathdee
Journal:  Am J Addict       Date:  2010 Jul-Aug

5.  Tackling HIV and drug addiction in Mexico.

Authors:  José Guadalupe Bustamante Moreno; José Antonio Izazola Licea; Carlos Rodríguez Ajenjo
Journal:  Lancet       Date:  2010-08-14       Impact factor: 79.321

6.  High prevalence of latent tuberculosis infection among injection drug users in Tijuana, Mexico.

Authors:  R S Garfein; R Lozada; L Liu; R Laniado-Laborin; T C Rodwell; R Deiss; J Alvelais; A Catanzaro; P G Chiles; S A Strathdee
Journal:  Int J Tuberc Lung Dis       Date:  2009-05       Impact factor: 2.373

7.  Correlates of HIV, sexually transmitted infections, and associated high-risk behaviors among male clients of female sex workers in Tijuana, Mexico.

Authors:  Thomas L Patterson; Shira Goldenberg; Manuel Gallardo; Remedios Lozada; Shirley J Semple; Prisci Orozovich; Daniela Abramovitz; Steffanie A Strathdee
Journal:  AIDS       Date:  2009-08-24       Impact factor: 4.177

8.  Predictors of needle exchange program utilization during its implementation and expansion in Tijuana, Mexico.

Authors:  Danielle M Smith; Dan Werb; Daniela Abramovitz; Carlos Magis-Rodriguez; Alicia Vera; Thomas L Patterson; Steffanie A Strathdee
Journal:  Am J Addict       Date:  2016-01-14

9.  Seroprevalence of select bloodborne pathogens and associated risk behaviors among injection drug users in the Paso del Norte region of the United States-Mexico border.

Authors:  Joan P Baumbach; Lily N Foster; Mark Mueller; Michelle Firestone Cruz; Sonia Arbona; Sharon Melville; Rebeca Ramos; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2008-11-16

10.  A qualitative assessment of stakeholder perceptions and socio-cultural influences on the acceptability of harm reduction programs in Tijuana, Mexico.

Authors:  Morgan M Philbin; Remedios Lozada; María Luisa Zúñiga; Andrea Mantsios; Patricia Case; Carlos Magis-Rodriguez; Carl A Latkin; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2008-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.